Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 9.01Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On January 2, 2019, Rebecca Robertson, age 58, was elected to the Company’s Board of Directors (the “Board”). Ms. Robertson will serve as a Class II director, with a term that expiresat the Annual Meeting of Stockholders of the Company to be held in 2021 or until her earlier resignation or removal.The Board has affirmatively determined that Ms. Robertson qualifies as an “independent director” under the NASDAQ Listing Rules.
Ms. Robertson is a founder and managing director at Versant Ventures where she specializes in investing in the areas of medical devices and diagnostics. In addition, through Longridge Business Advisors, she provides business advisory services.Prior to Versant, she served as senior vice president at Chiron Diagnostics, a division of Chiron Corporation, where she had responsibility for the critical care business unit in addition to leading the division’s business development efforts.Prior to joining Chiron, she was a co-founder and vice president at Egis, a consumer products company, and held senior management positions in operations and finance at Lifescan, a Johnson & Johnson Company. Ms. Robertson holds a B.S. in chemical engineering from Cornell University.
We believe Ms. Robertson’s experience in management and on boards of directors of companies in the healthcare industry, as well as her long-term investing experience, brings to our board critical skills related to scaling complex organizations and strategic planning that qualify her to serve as one of our directors.
Item 9.01Financial Statements and Exhibits
TANDEM DIABETES CARE INC Exhibit
EX-99.1 2 tndm-ex991_6.htm EX-99.1 PRESS RELEASE tndm-ex991_6.htm Exhibit 99.1 Media Contact: Steve Sabicer 714-907-6264 [email protected] Investor Contact: Susan Morrison 858-366-6900 x7005 [email protected] FOR IMMEDIATE RELEASE Tandem Diabetes Care Announces Appointment of Rebecca Robertson as Board Member San Diego,…
To view the full exhibit click here
About Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump’s cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.
